Questions remain however as to the J-shape, whether antihypertensive
treatment would still be beneficial in the extreme elderly,
those aged 90 or more, in a frailer cohort, particularly if residential
nursing care and in those with cognitive impairment.With increasing
age of those aged over 90 and 100 years, the balancing of benefit and
risk becomes more sophisticated.